This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Martin Alistair Hayes
Introduction
Martin Alistair Hayes is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. His work has led to the development of innovative compounds that hold promise for medical advancements.
Latest Patents
Hayes holds a patent for "Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases." This patent includes compounds of formula (I), which are designed to address various inflammatory conditions. His innovative approach has the potential to improve treatment options for patients suffering from these ailments.
Career Highlights
Hayes is currently associated with Glaxo Group Limited, a leading pharmaceutical company. His role at Glaxo has allowed him to focus on research and development, contributing to the advancement of medical science. With a total of 1 patent to his name, he has established himself as a valuable asset in the field of drug development.
Collaborations
Throughout his career, Hayes has collaborated with talented professionals, including Rachael Ann Ancliff and Caroline Mary Cook. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Martin Alistair Hayes is a dedicated inventor whose work in the pharmaceutical industry has the potential to make a significant impact on the treatment of inflammatory diseases. His contributions, along with his collaborations, highlight the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile